As chronic disease, GLP-1 adoption, and food for health reshape American healthcare, Kroger Health gathers leaders to explore the grocery store's emerging role as...
New research projects focus on behavioral safety, crash prevention and passive safetyANN ARBOR, Mich., June 2, 2026 /PRNewswire/ -- Before joining Toyota's Collaborative Safety Research Center (CSRC), Zhaonan Sun spent years...
Positive Results from Phase 2a Clinical TrialStudy met its primary endpoint demonstrating safety and tolerability of ifetroban in patients with high-risk solid tumorsTrial revealed promising...
BOSTON, June 2, 2026 /PRNewswire/ -- Point Wild, a leading global provider of AI-powered cybersecurity, today announced the acquisition of Funambol, a provider of personal...
Now available nationwide ahead of peak mosquito season, LIV 2.0 delivers scientifically proven, EPA-registered on-demand protection for backyards, restaurants, resorts and senior living.BEDFORD, Mass.,...
ohDEER Portland ME marks the company's twenty-first location.PORTLAND, Maine, June 2, 2026 /PRNewswire/ -- ohDEER, a leading provider of all-natural deer, tick, mosquito, and...
Advancing Proactive Health Management to Meet Chinese Families' Demand for Healthy LongevityHONG KONG and SHANGHAI, June 2, 2026 /PRNewswire/ -- As population aging accelerates...
Advancing Proactive Health Management to Meet Chinese Families' Demand for Healthy LongevityHONG KONG and SHANGHAI, June 2, 2026 /PRNewswire/ -- As population aging accelerates...
BILLINGSHURST, England, June 1, 2026 /PRNewswire/ -- As the world prepares to mark World Environment Day (5th June), Hydrachem is calling for renewed focus...
BILLINGSHURST, England, June 1, 2026 /PRNewswire/ -- As the world prepares to mark World Environment Day (5th June), Hydrachem is calling for renewed focus...
Saint Herblain (France), August 18, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that Health Canada has granted marketing authorization for its single-dose vaccine, IXCHIQ®, for the prevention of disease caused by the chikungunya virus in individuals aged 12 years and older. This announcement adds to the adult marketing authorization already received in Canada1 and complements the adolescent label extension received in Europe in April 20252.